Latest filing published 02 Mar 2023 for Abbott Laboratories, €96k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Fernando Mateus: trading record in brief
Fernando Mateus is a declared insider of Abbott Laboratories (chief executive), with filings sourced from SEC (Form 4). The record holds 9 filings, for trades running from 18 February 2022 to 28 February 2023.
The open-market record consists of 1 sale worth €265k, with no purchase. Besides market trades, the filings include 8 share grants.
The newest entry dates from 2 March 2023: a share grant of €96k, in Abbott Laboratories. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Fernando Mateus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,024 shares@ US$99.7726.7% of flowCommon shares without par valueSEC:0001415889-23-003911:0
- 10,560 shares0Common shares without par valueSEC:0001415889-23-003056:0
- 2,457 shares@ US$109.052973.3% of flowCommon shares without par valueSEC:0001415889-22-008001:0
- 10,482 shares0Common shares without par valueSEC:0001415889-22-001741:0
4 of 4 declarations
